Poonam Ashok Sonawane

  • Citations Per Year
Learn More
BACKGROUND AND PURPOSE Isotretinoin (13-cis-retinoic acid; 13-cRA) is a differentiation inducer used to treat minimal residual disease after myeloablative therapy for high-risk neuroblastoma.(More)
  • 1